फार्माकोलोगिया और टॉक्सिकोलोगिया

  • आईएसएसएन: 2174-8365
  • जर्नल एच-इंडेक्स: 1
में अनुक्रमित
  • ओसीएलसी- वर्ल्डकैट
  • शेरपा रोमियो
  • मेडिकल जर्नल संपादकों की अंतर्राष्ट्रीय समिति (आईसीएमजेई)
इस पृष्ठ को साझा करें

अमूर्त

Accelerating Drug Development for COVID-19: A Race against the Pandemic

Gibran Herman

The COVID-19 pandemic necessitated an urgent and accelerated approach to drug development. This abstract highlights the remarkable efforts made in developing drugs for COVID-19, including collaboration among scientists, repurposing existing drugs, and the triumph of vaccine development. The global scientific community joined forces, sharing knowledge and data to understand the virus better. Repurposing existing drugs allowed for faster clinical trials and promising results. The development and distribution of vaccines became a historic achievement, significantly reducing the spread and severity of the virus. Challenges such as safety assessments and equitable distribution were encountered. Lessons learned from this endeavor will shape future drug development and global pandemic preparedness. The COVID-19 drug development race showcases human resilience, scientific advancement, and the power of collaboration.

Keywords

Covid-19; Drug development; Existing drugs